Abstract
Hyperglycemia, caused in part by elevated hepatic glucose production (GP), is a hallmark feature of diabetes and obesity. The hypothalamus responds to hormones and nutrients to regulate hepatic GP and glucose homeostasis. This invited perspective focuses on the molecular signaling and biochemical pathways involved in the gluco-regulatory action of hypothalamic glucagon signaling and lipid sensing in health and disease. Recent evidence generated via genetic, molecular and chemical experimental approaches indicates that glucagon and lipid signaling independently trigger complementary hypothalamic mechanisms to lower GP. Thus, targeting hypothalamic glucagon or lipid signaling may have therapeutic potential in diabetes and obesity.
Similar content being viewed by others
References
Abraham MA, Yue JT, LaPierre MP, Rutter GA, Light PE, Filippi BM, Lam TK (2014) Hypothalamic glucagon signals through the KATP channels to regulate glucose production. Mol Metab 3:202–208
Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613–2616
Acosta-Martínez M, Levine JE (2007) Regulation of KATP channel subunit gene expression by hyperglycemia in the mediobasal hypothalamus of female rats. Am J Physiol Endocrinol Metab 292:E1801–E1807
Agarwala GC, Bapat SK (1977) Effect of centrally administered glucagon on blood glucose levels in dogs. Indian J Med Res 66:323–330
Agarwala GC, Mishra R, Jaiswal G, Bapat V (1989) Effect of centrally administered glucagon on liver glycogen & enzymes in anaesthetised dogs. Indian J Med Res 90:372–378
Amatruda JM, Livingston JN (2003) Glucagon. In: Porte D, Sherwin RS, Baron A, Ellenberg M, Rifkin H (eds) Ellenberg and Rifkin’s diabetes mellitus, 6th edn. McGraw-Hill, Ann Arbor, pp 97–115
Béguin P, Nagashima K, Nishimura M, Gonoi T, Seino S (1999) PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J 18:4722–4732
Belgardt BF, Okamura T, Brüning JC (2009) Hormone and glucose signalling in POMC and AgRP neurons. J Physiol 587:5305–5314
Bomboy JD, Lewis SB, Lacy WW, Sinclair-Smith BC, Liljenquist JE (1977) Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man. Diabetes 26:4–177
Brand CL, Rolin B, Jørgensen PN, Svendsen I, Kristensen JS, Holst JJ (1994) Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats. Diabetologia 37:985–993
Choi CS, Savage DB, Abu-Elheiga L, Liu Z-X, Kim S, Kulkarni A, Distefano A, Hwang Y-J, Reznick RM, Codella R, Zhang D, Cline GW, Wakil SJ, Shulman GI (2007) Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA 104:16480–16485
Damm E, Buech TRH, Gudermann T, Breit A (2012) Melanocortin-induced PKA activation inhibits AMPK activity via ERK-1/2 and LKB-1 in hypothalamic GT1-7 cells. Mol Endocrinol 26:643–654
Dogrukol-Ak D, Tore F, Tuncel N (2004) Passage of VIP/PACAP/secretin family across the blood-brain barrier: therapeutic effects. Curr Pharm Des 10:1325–1340
Eigler N, Saccà L, Sherwin RS (1979) Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. J Clin Invest 63:114–123
Felig P, Wahren J, Hendler R (1976) Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. J Clin Invest 58:761–765
Filippi BM, Yang CS, Tang C, Lam TKT (2012) Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab 16:500–510
Gelling RW, Du XQ, Dichmann DS, Romer J, Huang H, Cui L, Obici S, Tang B, Holst JJ, Fledelius C, Johansen PB, Rossetti L, Jelicks LA, Serup P, Nishimura E, Charron MJ (2003) Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA 100:1438–1443
Gerich JE (1981) Physiology of glucagon. Int Rev Physiol 24:243–275
Hamilton JA, Brunaldi K (2007) A model for fatty acid transport into the brain. J Mol Neurosci 33:12–17
Hoehn KL, Turner N, Swarbrick MM, Wilks D, Preston E, Phua Y, Joshi H, Furler SM, Larance M, Hegarty BD, Leslie SJ, Pickford R, Hoy AJ, Kraegen EW, James DE, Cooney GJ (2010) Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. Cell Metab 11:70–76
Honda K, Kamisoyama H, Saito N, Kurose Y, Sugahara K, Hasegawa S (2007) Central administration of glucagon suppresses food intake in chicks. Neurosci Lett 416:198–201
Honda K, Kamisoyama H, Uemura T, Yanagi T, Saito N, Kurose Y, Sugahara K, Katoh K, Hasegawa S (2012) The mechanism underlying the central glucagon-induced hyperglycemia and anorexia in chicks. Comp Biochem Physiol A: Mol Integr Physiol 163:260–264
Hoosein NM, Gurd RS (1984) Identification of glucagon receptors in rat brain. Proc Natl Acad Sci USA 81:4368–4372
Inokuchi A, Oomura Y, Shimizu N, Yamamoto T (1986) Central action of glucagon in rat hypothalamus. Am J Physiol 250:R120–R126
Jiang G, Zhang BB (2003) Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284:E671–E678
Johnson DG, Goebel CU, Hruby VJ, Bregman MD, Trivedi D (1982) Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science 215:1115–1116
Kahn BB, Alquier T, Carling D, Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15–25
Kishore P, Boucai L, Zhang K, Li W, Koppaka S, Kehlenbrink S, Schiwek A, Esterson YB, Mehta D, Bursheh S, Su Y, Gutierrez-Juarez R, Muzumdar R, Schwartz GJ, Hawkins M (2011) Activation of K(ATP) channels suppresses glucose production in humans. J Clin Invest 121:4916–4920
Kong D, Vong L, Parton LE, Ye C, Tong Q, Hu X, Choi B, Brüning JC, Lowell BB (2010) Glucose stimulation of hypothalamic MCH neurons involves K(ATP) channels, is modulated by UCP2, and regulates peripheral glucose homeostasis. Cell Metab 12:545–552
Könner AC, Janoschek R, Plum L, Jordan SD, Rother E, Ma X, Xu C, Enriori P, Hampel B, Barsh GS, Kahn CR, Cowley Ma, Ashcroft FM, Brüning JC (2007) Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab 5:438–449
Kurose Y, Kamisoyama H, Honda K, Azuma Y, Sugahara K, Hasegawa S, Kobayashi S (2009) Effects of central administration of glucagon on feed intake and endocrine responses in sheep. Anim Sci J 80:686–690
Lam TK (2010) Neuronal regulation of homeostasis by nutrient sensing. Nat Med 16:392–395
Lam TK, Pocai A, Gutierrez-Juarez R, Obici S, Bryan J, Aguilar-Bryan L, Schwartz GJ, Rossetti L (2005) Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 11:320–327
Le Foll C, Irani BG, Magnan C, Dunn-Meynell AA, Levin BE (2009) Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing. Am J Physiol Regul Integr Comp Physiol 297:R655–R664
Le Foll C, Dunn-Meynell AA, Musatov S, Magnan C, Levin BE (2013) FAT/CD36: a major regulator of neuronal fatty acid sensing and energy homeostasis in rats and mice. Diabetes 62:2709–2716
Light PE, Bladen C, Winkfein RJ, Walsh MP, French RJ (2000) Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci USA 97:9058–9063
López M, Varela L, Vazquez MJ, Rodriguez-Cuenca S, Gonzalez CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, Martinez de Morentin PB, Tovar S, Nogueiras R, Carling D, Lelliott C, Gallego R, Oresic M, Chatterjee K, Saha AK, Rahmouni K, Dieguez C, Vidal-Puig A (2010) Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med 16:1001–1008
Marubashi S, Tominaga M, Katagiri T, Yamatani K, Yawata Y, Hara M, Sasaki H (1985) Hyperglycaemic effect of glucagon administered intracerebroventricularly in the rat. Acta Endocrinol (Copenh) 108:6–10
McGarry JD (1992) What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766–770
Mighiu PI, Yue JT, Filippi BM, Abraham MA, Chari M, Lam CK, Yang CS, Christian NR, Charron MJ, Lam TK (2013) Hypothalamic glucagon signaling inhibits hepatic glucose production. Nat Med 19:766–772
Minokoshi Y, Alquier T, Furukawa N, Kim Y-B, Lee A, Xue B, Mu J, Foufelle F, Ferré P, Birnbaum MJ, Stuck BJ, Kahn BB (2004) AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428:569–574
Mitchell RW, Edmundson CL, Miller DW, Hatch GM (2009) On the mechanism of oleate transport across human brain microvessel endothelial cells. J Neurochem 110:1049–1057
Morgan K, Obici S, Rossetti L (2004) Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem 279:31139–31148
Moritz W, Leech CA, Ferrer J, Habener JF (2001) Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells. Endocrinology 142:129–138
Morton GJ, Schwartz MW (2011) Leptin and the central nervous system control of glucose metabolism. Physiol Rev 91:389–411
Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz MW (2005) Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab 2:411–420
Müller WA, Faloona GR, Aguilar-Parada E, Unger RH (1970) Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med 283:109–115
Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L (2002a) Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51:271–275
Obici S, Zhang BB, Karkanias G, Rossetti L (2002b) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8:1376–1382
Obici S, Feng Z, Arduini A, Conti R, Rossetti L (2003) Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9:756–761
Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, Rossetti L (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434:1026–1031
Pocai A, Lam TK, Obici S, Gutierrez-Juarez R, Muse ED, Arduini A, Rossetti L (2006) Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest 116:1081–1091
Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan-Giri A, Pennathur S, Baskin DG, Heinecke JW, Woods SC, Schwartz MW, Niswender KD (2009) Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 296:E1003–E1012
Rapoport SI (1996) In vivo labeling of brain phospholipids by long-chain fatty acids: relation to turnover and function. Lipids 31(Suppl):S97–S101
Rapoport SI, Chang MC, Spector AA (2001) Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 42:678–685
Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB (1987) Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64:106–110
Ross R, Wang PY, Chari M, Lam CK, Caspi L, Ono H, Muse ED, Li X, Gutierrez-Juarez R, Light PE, Schwartz GJ, Rossetti L, Lam TK (2008) Hypothalamic protein kinase C regulates glucose production. Diabetes 57:2061–2065
Sandoval DA, Bagnol D, Woods SC, D’Alessio DA, Seeley RJ (2008) Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57:2046–2054
Schwartz MW, Seeley RJ, Tschöp MH, Woods SC, Morton GJ, Myers MG, D’Alessio D (2013) Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 503:59–66
Su Y, Lam TK, He W, Pocai A, Bryan J, Aguilar-Bryan L, Gutierrez-Juarez R (2012) Hypothalamic leucine metabolism regulates liver glucose production. Diabetes 61:85–93
Taylor SI (1999) Deconstructing type 2 diabetes. Cell 97:9–12
Unson CG, Gurzenda EM, Merrifield RB (1989) Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist. Peptides 10:1171–1177
Vranic M, Kawamori R, Wrenshall GA (1975) The role of insulin and glucagon in regulating glucose turnover in dogs during exercise. Med Sci Sports 7:27–33
Wang R, Cruciani-Guglielmacci C, Migrenne S, Magnan C, Cotero VE, Routh VH (2006) Effects of oleic acid on distinct populations of neurons in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels. J Neurophysiol 95:1491–1498
Wetsel WC, Eraly SA, Whyte DB, Mellon PL (1993) Regulation of gonadotropin-releasing hormone by protein kinase-A and -C in immortalized hypothalamic neurons. Endocrinology 132:2360–2370
Yang CS, Lam CK, Chari M, Cheung GWC, Kokorovic A, Gao S, Leclerc I, Rutter GA, Lam TK (2010) Hypothalamic AMP-activated protein kinase regulates glucose production. Diabetes 59:2435–2443
Yue JT, Lam TK (2012) Lipid Sensing and insulin resistance in the brain. Cell Metab 15:646–655
Acknowledgments
The work discussed in this review produced by the Lam laboratory was supported by research grants from the Canadian Diabetes Association (OG-3–13-4156-TL) and the Canadian Institute of Health Research (MOP-86554). Mary P. LaPierre is supported by an Ontario Graduate Scholarship and a UHN Unilever Graduate Fellowship in Neuroscience. Mona A. Abraham is supported by a Banting and Best Diabetes Center graduate scholarship. Jessica T. Y. Yue is supported by post-doctoral fellowships from the Canadian Institutes of Health Research and Canadian Diabetes Association. Tony K. T. Lam holds the J. K. McIvor (1915–1942) Endowed Chair in Diabetes Research and the Canada Research Chair in Obesity at the Toronto General Research Institute and the University of Toronto.
Author information
Authors and Affiliations
Corresponding author
Additional information
Mary P. LaPierre and Mona A. Abraham have contributed equally to this invited perspective.
Rights and permissions
About this article
Cite this article
LaPierre, M.P., Abraham, M.A., Filippi, B.M. et al. Glucagon and lipid signaling in the hypothalamus. Mamm Genome 25, 434–441 (2014). https://doi.org/10.1007/s00335-014-9510-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-014-9510-6